title: Phase 3 trial with the RTS,S/AS01 malaria vaccine shows protection against clinical and severe malaria in infants and children in Africa.
authors.affiliation: Faculty of Infectious and Tropical Diseases, Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Targett
mesh_terms: D006801:Humans; D017780:Malaria Vaccines / Q000008:administration & dosage*; D016778:Malaria, Falciparum / Q000517:prevention & control*; D014611:Vaccination / Q000592:standards*
chemical_list: D017780:Malaria Vaccines